Ritter R, Pillny M, Grabitz K, Sandmann W
Klinik für Gefässchirurgie und Nierentransplantation, Heinrich-Heine-Universität Düsseldorf.
Dtsch Med Wochenschr. 1998 Sep 11;123(37):1059-64. doi: 10.1055/s-2007-1024125.
Increasing numbers of vena canal filters are being implanted to prevent pulmonary embolism, which are mainly the consequence of deep vein and pelvic vein thrombosis. Can a filter be removed again in case of complications arising from it? What is the risk of such operative explantation? What is the subsequent risk of pulmonary embolism?
In nine patients (5 males, 4 females; mean age 45 (30-39 years) who had vena caval filters implanted because of thromboembolism despite anticoagulation, complications due to the filter required its operative removal and thrombectomy of the large veins 3 days to 48 months after implantation in the inferior vena cava (IVC). One inguinal arteriovenous fistula (due to perforation of rods of a displaced filter) were closed. The patients' case note were retrospectively analysed and eight of the nine patients' were reexamined according to a standardized procedure a mean of 20 months after removal of the filter.
Explantation of the filter had been successful in all patients. But there were two nonfatal postoperative complications: a pulmonary embolus and a paradoxical cerebral embolus. In one patient a segmental stenosis of the IVC with retroperitoneal collateral circulation was found at operation. All but one of 16 pelvic veins that had thrombectomies performed at the time of filter explanation were patent, as were the IVCs in seven of the eight re-examined patients. None of the patients had evidence of postoperative pulmonary embolism.
Vena caval filters can be explanted with a low operative risk. After removal and venous thrombectomy, implantation of another caval filter is unnecessary. As anticoagulation properly monitored is almost always an effective measure in the prevention of pulmonary thromboembolism, filter implantation should be performed only on the strictest indication, as an ultimate step.
为预防肺栓塞,越来越多的腔静脉滤器被植入,肺栓塞主要是深静脉和盆腔静脉血栓形成的后果。如果滤器出现并发症,能否再次取出?这种手术取出的风险是什么?后续发生肺栓塞的风险又是什么?
9例患者(5例男性,4例女性;平均年龄45岁(30 - 39岁))因尽管进行了抗凝治疗仍发生血栓栓塞而植入腔静脉滤器,滤器植入下腔静脉(IVC)后3天至48个月,因滤器相关并发症需要手术取出滤器并进行大静脉血栓切除术。1例腹股沟动静脉瘘(因移位滤器的杆穿孔所致)被修复。对患者的病历进行回顾性分析,9例患者中有8例在滤器取出后平均20个月按照标准化程序进行复查。
所有患者滤器取出均成功。但有2例非致命的术后并发症:1例肺栓塞和1例反常脑栓塞。1例患者术中发现IVC节段性狭窄并伴有腹膜后侧支循环。滤器取出时进行血栓切除术的16条盆腔静脉中,除1条外其余均通畅,8例复查患者中有7例IVC通畅。所有患者均无术后肺栓塞的证据。
腔静脉滤器可以在低手术风险下取出。取出滤器并进行静脉血栓切除术后,无需再植入腔静脉滤器。由于适当监测的抗凝治疗几乎总是预防肺血栓栓塞的有效措施,滤器植入应仅在最严格的指征下进行,作为最后一步。